Search

Your search keyword '"Metzler, Ivana von"' showing total 9 results
Start Over Author "Metzler, Ivana von" Database Supplemental Index
9 results on '"Metzler, Ivana von"'

3. Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Author

Straka, Christian, Schaefer-Eckart, Kerstin, Hertenstein, Bernd, Bassermann, Florian, Salwender, Hans, Langer, Christian, Krönke, Jan, Kull, Miriam, Schilling, Georgia, Schieferdecker, Aneta, Engelhardt, Monika, Knop, Stefan, Reusch, Julia, Roesler, Wolf, Metzner, Bernd, Hebart, Holger, Reichle, Albrecht, Grube, Matthias, Frickhofen, Norbert, Gerecke, Christian, Fuhrmann, Stephan, Jung, Wolfram, Gramatzki, Martin, Decker, Thomas, Dechow, Tobias, Greiner, Jochen, Brümmendorf, Tim H., Ababei, Juliana, Metzler, Ivana von, Naumann, Ralph, Fritz, Elisabeth, Hentrich, Marcus, Bojko, Peter, Kubin, Thomas, Schmidt, Christian, Kaufmann, Martin, Schmidt, Burkhard, Hinke, Axel, and Einsele, Hermann

Published
2022
Full Text
View/download PDF

5. Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Author

Straka, Christian, Schaefer-Eckart, Kerstin, Hertenstein, Bernd, Bassermann, Florian, Salwender, Hans, Langer, Christian, Krönke, Jan, Kull, Miriam, Schilling, Georgia, Schieferdecker, Aneta, Engelhardt, Monika, Knop, Stefan, Reusch, Julia, Roesler, Wolf, Metzner, Bernd, Hebart, Holger, Reichle, Albrecht, Grube, Matthias, Frickhofen, Norbert, Gerecke, Christian, Fuhrmann, Stephan, Jung, Wolfram, Gramatzki, Martin, Decker, Thomas, Dechow, Tobias, Greiner, Jochen, Brümmendorf, Tim H., Ababei, Juliana, Metzler, Ivana von, Naumann, Ralph, Fritz, Elisabeth, Hentrich, Marcus, Bojko, Peter, Kubin, Thomas, Schmidt, Christian, Kaufmann, Martin, Schmidt, Burkhard, Hinke, Axel, and Einsele, Hermann

Published
2022
Full Text
View/download PDF

7. The potential of proteasome inhibitors in cancer therapy

Author

Sterz, Jan, Metzler, Ivana von, Hahne, Jens-Claus, Lamottke, Britta, Rademacher, Jessica, Heider, Ulrike, Terpos, Evangelos, and Sezer, Orhan

Abstract

Background: The ubiquitin-proteasome system has become a promising novel molecular target in cancer due to its critical role in cellular protein degradation, its interaction with cell cycle and apoptosis regulation and its unique mechanism of action. Objective: This review focuses both on preclinical results and on data from clinical trials with proteasome inhibitors in cancer. Methods: Results in hematological malignancies and solid tumors were included, and important data presented in abstract form were considered in this review. Results/conclusion: Bortezomib as first-in-class proteasome inhibitor has proven to be highly effective in some hematological malignancies, overcomes conventional chemoresistance, directly induces cell cycle arrest and apoptosis, and also targets the tumor microenvironment. It has been granted approval by the FDA for relapsed multiple myeloma, and recently for relapsed mantle cell lymphoma. Combination chemotherapy regimens have been developed providing high remission rates and remission quality in frontline treatment or in the relapsed setting in multiple myeloma. The combination of proteasome inhibition with novel targeted therapies is an emerging field in oncology. Moreover, novel proteasome inhibitors, such as NPI-0052 and carfilzomib, have been developed. This review summarizes our knowledge of the ubiquitin-proteasome system and recent data from cancer clinical trials.

Published
2008
Full Text
View/download PDF

9. Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

Author

Couto, Maria Eduarda, Borges, Marina, Bento, Maria José, Calisto, Rita, Magalhaes, Marta Daniela Marques, Ajmal, Adil, Niklas, Nicolas, Dushkin, Kirill, MacDougall, Finlay, Wolf, Andrea, Shaid, Shabnam, and Metzler, Ivana von

Abstract

Metzler: GSK: Consultancy; Takeda: Consultancy; Janssen: Consultancy; AstraZeneca: Consultancy; Amgen: Consultancy; BMS: Consultancy; Sanofi: Consultancy; Pfizer: Consultancy.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results